FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks

• US 9,493,779 B2
• Filed: 09/05/2013
• Issued: 11/15/2016
• Est. Priority Date: 09/07/2012
• Status: Active Grant

• Current Assignee: Dow Agrosciences LLC (Corteva, Inc.), Sangamo Therapeutics, Inc.
• Original Assignee: Dow Agrosciences LLC (Corteva, Inc.), Sangamo Biosciences, Inc. (Sangamo Therapeutics, Inc.)
• Inventors: Ainley, William Michael, Webb, Steven R., Samuel, Pon, Guschin, Dmitry Y., Miller, Jeffrey C., Zhang, Lei
• Primary Examiner(s): Page, Brent
• Assistant Examiner(s): Keogh, Matthew
• Application Number:
  US14/019,293
• Publication Number:
  US 20140090116A1
• Time in Patent Office: 1,167 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A01H 5/10 Seeds
• CPC Class Codes: A01H 6/542 Glycine max [soybean]
• CPC Class Codes: C12N 15/102 Mutagenizing nucleic acids
• CPC Class Codes: C12N 15/8216 Methods for controlling, regulating or enhancing expression of transgenes in plant cells
• CPC Class Codes: C12N 15/8247 involving modified lipid metabolism, e.g. seed oil composition
• CPC Class Codes: C12N 15/902 using homologous recombination
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: C12Y 301/00 Hydrolases acting on ester bonds (3.1)
• CPC Class Codes: Y02A 40/146 Genetically Modified [GMO] plants, e.g. transgenic plants

Abstract

Methods and compositions for gene disruption, gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a soybean cell, to generate a break in the FAD2 gene and then optionally integrating into the break a nucleic acid molecule of interest is disclosed.

Claims

1. A method for integrating a nucleic acid sequence of interest into a specific site in the genome of a soybean cell, the method comprising:

cleaving, in a site specific manner, a target site within any of SEQ ID NOs;

14 to 20 in a FAD2 gene in a soybean cell, to thereby generate a break in the FAD2 gene;

integrating into the break an exogenous nucleic acid sequence of interest.

2. The method according to claim 1, wherein the FAD2 gene is a FAD2 2.3, FAD2 2.6 gene, or both.

3. The method according to claim 1, wherein the cleaving in a site specific manner comprises introducing a fusion protein comprising a DNA-binding domain and a cleavage domain or cleavage half-domain into the cell, wherein the fusion protein binds with specificity to the target site and cleaves at or near the target site to thereby generate the break.

4. The method according to claim 3, wherein the DNA-binding domain is selected from the group consisting of a meganuclease DNA-binding domain, a leucine zipper DNA-binding domain, a transcription activator-like (TAL) DNA-binding domain, a RNA-guided CRISPR-Cas9, a recombinase, a zinc finger protein DNA-binding domain, and chimeric combinations of any of the foregoing.

5. The method according to claim 3, wherein the cleavage domain or cleavage half-domain is selected from the group consisting of a cleavage half-domain from a type IIS restriction endonuclease, a cleavage half-domain from FokI endonuclease, a cleavage half-domain from StsI endonuclease, and a homing endonuclease.

6. The method according to claim 3, wherein the fusion protein is a zinc finger nuclease.

7. The method according to claim 6, wherein the zinc finger nuclease comprises from three to six zinc finger domains, each zinc finger domain comprising a recognition helix region, wherein the zinc finger protein comprises the recognition helix regions ordered and shown in a single row of Table 2.

8. The method according to claim 2, wherein the cleaving in a site specific manner is specific for some but not all copies of FAD2 2.3 and FAD2 2.6.

11. The method according to claim 1, wherein the break is a double-strand break.

12. The method according to claim 1, wherein the nucleic acid sequence of interest is heterologous to the cell.

13. The method according to claim 1, wherein the nucleic acid sequence of interest encodes a protein.

14. The method according to claim 1, wherein the nucleic acid sequence of interest comprises a DNA-binding domain binding site.

15. The method according to claim 13, wherein the nucleic acid sequence of interest is selected from the group consisting of insecticidal resistance genes, herbicide tolerance genes, nitrogen use efficiency genes, water use efficiency genes, nutritional quality genes, DNA binding genes, and selectable marker genes.

16. The method according to claim 3, wherein the fusion protein is introduced into the cell as a polynucleotide encoding the fusion protein.

9. A soybean plant comprising a soybean cell modified by the following method:

cleaving, in a site specific manner, a target site in a FAD2 gene in a soybean cell, to generate one double-stranded break within any of SEQ ID NOs;

14 to 20 in the FAD2 gene; and

integrating into the break an exogenous nucleic acid sequence of interest.

10. The plant according to claim 9, wherein integrating into the break the nucleic acid sequence of interest does not have an adverse impact on the agronomic or quality properties of the plant.

17. A transgenic soybean cell comprising an exogenous nucleotide sequence of interest integrated within any of SEQ ID NOs:

14 to 20 of a FAD2 2.3 and/or FAD2 2.6 gene.

18. The transgenic cell of claim 17, wherein the nucleotide sequence is heterologous to the cell.

19. The transgenic cell of claim 17, wherein the nucleotide sequence is integrated into some but not all copies of the FAD2 2.3 and/or FAD2 2.6 gene.

20. A transgenic soybean plant or seed, comprising the transgenic cell of claim 17.

21. The transgenic plant of claim 20, wherein presence of the nucleotide sequence in the FAD2 2.3 and FAD2 2.6 gene does not have an adverse impact on the agronomic or quality properties of the plant.

22. A method of cleaving a FAD2 loci in a soybean cell, the method comprising:

introducing a fusion protein comprising a DNA-binding domain and a cleavage domain or cleavage half-domain into the cell, wherein the fusion protein binds with specificity to a target site within any of SEQ ID NOs;

14 to 20 in the FAD2 loci and cleaves to generate a break.

23. The method according to claim 22, further comprising integrating into the break a nucleic acid molecule of interest.

24. The method according to claim 22, wherein the FAD2 loci is a FAD2 2.3 gene, FAD2 2.6 gene, or both.

25. The method according to claim 22, wherein the DNA-binding domain is selected from the group consisting of a meganuclease DNA-binding domain, a leucine zipper DNA-binding domain, a transcription activator-like (TAL) DNA-binding domain, a RNA-guided CRISPR-Cas9, a recombinase, a zinc finger protein DNA-binding domain, and chimeric combinations of any of the foregoing.

26. The method according to claim 22, wherein the cleavage domain or cleavage half-domain is selected from the group consisting of a cleavage half-domain from a type IIS restriction endonuclease, a cleavage half-domain from FokI endonuclease, a cleavage half-domain from StsI endonuclease, and a homing endonuclease.

27. The method according to claim 22, wherein the fusion protein is a zinc finger nuclease.

28. The method according to claim 27, wherein the zinc finger nuclease comprises five or six zinc finger domains ordered finger 1 to finger 5 or finger 1 to finger 6, each zinc finger domain comprising a recognition helix region, wherein the zinc finger protein comprises the recognition helix regions ordered and shown in a single row of Table 2.

29. The method according to claim 22, wherein the cleaving is specific for some but not all copies FAD2 2.3 and FAD2 2.6.